REGENXBIO
RGNX
£6.30
Share price
-4.32%
Change (1 day)
-43.67%
Change (1 year)
Categories
REGENXBIO (RGNX) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : £0.16 Billion
According to REGENXBIO's latest financial reports the company's total liabilities are £0.16 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
REGENXBIO - Total liabilities on balance sheet (from 2014 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | £0.16 B | -20.12% |
| 2023-12-31 | £0.20 B | -21.46% |
| 2022-12-31 | £0.26 B | 1.19% |
| 2021-12-31 | £0.25 B | 6.85% |
| 2020-12-31 | £0.24 B | 566.23% |
| 2019-12-31 | £36.38 M | 32.08% |
| 2018-12-31 | £27.54 M | 137.91% |
| 2017-12-31 | £11.57 M | 29.94% |
| 2016-12-31 | £8.91 M | 188.82% |
| 2015-12-31 | £3.08 M | -47.73% |
| 2014-12-31 | £5.9 M | 109.23% |
| 2013-12-31 | £2.82 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | £17.31 M | -89.33% | 🇺🇸 USA |